Ameritas Investment Partners’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.3K | Hold |
14,205
| – | – | ﹤0.01% | 2013 |
|
|
2025
Q1 | $78K | Hold |
14,205
| – | – | ﹤0.01% | 1863 |
|
|
2024
Q4 | $48.2K | Hold |
14,205
| – | – | ﹤0.01% | 2206 |
|
|
2024
Q3 | $40.5K | Buy |
14,205
+4,275
| +43% | +$12.2K | ﹤0.01% | 2314 |
|
|
2024
Q2 | $22.3K | Hold |
9,930
| – | – | ﹤0.01% | 2562 |
|
|
2024
Q1 | $21.9K | Hold |
9,930
| – | – | ﹤0.01% | 2531 |
|
|
2023
Q4 | $23.3K | Hold |
9,930
| – | – | ﹤0.01% | 2513 |
|
|
2023
Q3 | $18.5K | Hold |
9,930
| – | – | ﹤0.01% | 2573 |
|
|
2023
Q2 | $26K | Hold |
9,930
| – | – | ﹤0.01% | 2421 |
|
|
2023
Q1 | $16.2K | Hold |
9,930
| – | – | ﹤0.01% | 2537 |
|
|
2022
Q4 | $12.3K | Hold |
9,930
| – | – | ﹤0.01% | 2753 |
|
|
2022
Q3 | $15K | Hold |
9,930
| – | – | ﹤0.01% | 2659 |
|
|
2022
Q2 | $15K | Buy |
+9,930
| New | +$15K | ﹤0.01% | 2700 |
|
|
2021
Q2 | – | Sell |
-3,103
| Closed | -$14K | – | 3246 |
|
|
2021
Q1 | $14K | Hold |
3,103
| – | – | ﹤0.01% | 2724 |
|
|
2020
Q4 | $15K | Hold |
3,103
| – | – | ﹤0.01% | 2628 |
|
|
2020
Q3 | $18K | Hold |
3,103
| – | – | ﹤0.01% | 2442 |
|
|
2020
Q2 | $8K | Buy |
3,103
+1,415
| +84% | +$3.65K | ﹤0.01% | 2844 |
|
|
2020
Q1 | $3K | Hold |
1,688
| – | – | ﹤0.01% | 2932 |
|
|
2019
Q4 | $12K | Hold |
1,688
| – | – | ﹤0.01% | 2669 |
|
|
2019
Q3 | $17K | Hold |
1,688
| – | – | ﹤0.01% | 2487 |
|
|
2019
Q2 | $19K | Hold |
1,688
| – | – | ﹤0.01% | 2484 |
|
|
2019
Q1 | $17K | Buy |
1,688
+1,143
| +210% | +$11.5K | ﹤0.01% | 2473 |
|
|
2018
Q4 | $9K | Hold |
545
| – | – | ﹤0.01% | 2717 |
|
|
2018
Q3 | $10K | Buy |
+545
| New | +$10K | ﹤0.01% | 2837 |
|